Recent research has suggested that activating transcription factor 4 contributes to decreased fetal hemoglobin level through its binding to potent negative regulators of HbF, such as BCL11A and MYB.
[Annals of Hematology]
Home Newsletters Hematopoiesis News Activating Transcription Factor 4 in Erythroid Development and β-Thalassemia: A Powerful Regulator...
